Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 6:23 PM ET | Feedback | Site Changes | Help
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
View Ticker Page (MRK)
Results 51 - 60 of 317 : « Previous 678910Next »
Recs
Leanna1025 (< 20) Submitted: 4/02/08 7:12 PM : Start Price: $36.38 MRK Score: -7.03
Two words.....Vytorin what?
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
petrus1700 (74.29) Submitted: 4/02/08 3:54 PM : Start Price: $36.44 MRK Score: 7.20
over sold
Matt8265 (92.20) Submitted: 4/01/08 8:35 AM : Start Price: $37.60 MRK Score: 3.56
What an overreaction to an already beat up stock. I'll take a bet on Merck at 38.00 beans any day.
codergrrl (46.42) Submitted: 1/07/08 11:18 AM : Start Price: $56.03 MRK Score: -15.83
Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of products for human and animal health. Note: Even though trouble was on the horizon (See: Vioxx) I think this company has a chance of swinging it back around.
FoolishG8R (96.68) Submitted: 3/31/08 10:35 PM : Start Price: $37.60 MRK Score: 3.56
Great defensive stock. Getting too beat up over litigation risks in a shaky market. On the good side of an aging America. Remember when everybody wanted to own a piece of this, they will again. Get in now, beat the rush.
bridgeboy0 (31.57) Submitted: 3/31/08 3:26 PM : Start Price: $36.83 MRK Score: 4.25
Over-reaction to the Vytorin news.
VExplorer (76.47) Submitted: 3/31/08 1:06 PM : Start Price: $36.96 MRK Score: 4.15
Oversold today on negative news
kbmartin2 (< 20) Submitted: 4/03/08 3:48 PM : Start Price: $37.48 MRK Score: 5.19
oversold on ezetimibe scare
mcingram1976 (44.40) Submitted: 4/08/08 4:12 PM : Start Price: $40.09 MRK Score: 0.65
I believe the sell off in health care & biotech is greatly over done. This stock is farily valued, a solid balance sheet, P/E ratios, and overall growth potential. Once the market realizes this and the additional upside potential to capture the baby ...
TSHSU (32.87) Submitted: 4/14/08 4:09 AM : Start Price: $40.28 MRK Score: -1.64
Merck has been beaten down significantly because of the bad news about Vitorin and Vivox lawsuit. These news are not new. It just got bad publicity recently. The market reacts negatively recently. So it is time to buy and Merck will recover pretty so...
Terms & Conditions
RSS Headlines
Fool UK